Abstract 2277: Loss of nuclear localized and tyrosine phosphorylated Stat5: A predictor of poor clinical outcome and increased risk of antiestrogen therapy failure in breast cancer

Journal Article

Full Text

Duke Authors

Cited Authors

  • Peck, AR; Witkiewicz, AK; Liu, C; Stringer, GA; Klimowicz, AC; Pequignot, E; Freydin, B; Tran, TH; Yang, N; Rosenberg, AL; Hooke, JA; Kovatich, AJ; Nevalainen, MT; Shriver, CD; Hyslop, T; Sauter, G; Rimm, DL; Magliocco, AM; Rui, H

Published Date

  • April 15, 2011

Published In

  • Clinical Research

Published By

Digital Object Identifier (DOI)

  • 10.1158/1538-7445.am2011-2277